CHO Cell Line

Thermo Fisher Scientific Launches New Biologics Development Platform to Accelerate Innovation

By BiotechReality Business Intelligence Desk
4 April 2026

Thermo Fisher Scientific has unveiled the Gibco CHOvantage GS, a next-generation biologics development platform designed to accelerate timelines to the clinic while ensuring regulatory compliance and scalability.

News Research

A long-standing challenge with CHO cell line is solved by a new understanding of lactic acid metabolism in cells

By Editor's Desk
15 January 2025

Chinese hamster ovary (CHO) cells are frequently used to produce protein-based medications for the treatment of cancer, autoimmune disorders, and other conditions. A multinational team [Read More…]

Tag: CHO Cell Line

Thermo Fisher Scientific Launches New Biologics Development Platform to Accelerate Innovation

A long-standing challenge with CHO cell line is solved by a new understanding of lactic acid metabolism in cells

Areas Covered

Discover More

Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year

Charles River Magellan Collaboration Backs Zelestrocel Osteoarthritis Therapy With cGMP NGS Viral Safety Testing

Johnson & Johnson Q3 2026 Results: J&J Raises 2026 Guidance as OTTAVA, IMAAVY and RYBREVANT FASPRO Advance

IQVIA Veeva Clinical Operations Expansion: IQVIA Selects Veeva CTMS, eTMF, Study Startup and Site Connect as Enterprise Standards

Regeneron Pasatru (garetosmab-grts) Shows Zero New HO Lesions in Adult FOP Patients in OPTIMA Extension

Johnson & Johnson ICOTYDE (icotrokinra) Posts Two-Year Phase 3 Results in Adults and Adolescents With Plaque Psoriasis